Moreover, we discuss evidence that inhibition of Nav1.8 is effective at acutely rescuing these phenotypes and discuss the potential of Nav1.8 as a therapeutic target for the treatment of PTHS (Fig. 1). Here, SCN10A is linked to Pitt-Hopkins syndrome.